Side-by-side comparison of AI visibility scores, market position, and capabilities
Atomic AI is a San Francisco biotech using AI and structural biology to design RNA-targeting therapeutics; founded in 2021 by Raphael Townshend (AlphaFold co-contributor); raised $35M Series A in 2022;
Atomic AI is a biotechnology company founded in 2021 and headquartered in San Francisco, California, at the intersection of artificial intelligence and RNA biology. The company was co-founded by Raphael Townshend, a key contributor to machine learning methods for molecular structure prediction including work related to AlphaFold, reflecting the founding team's deep expertise in applying AI to three-dimensional molecular structure. Atomic AI's platform combines machine learning with structural biology to understand and predict RNA structure and RNA-protein interactions — a capability central to designing drugs that target RNA molecules rather than proteins.
DNAnexus is the leading precision health data cloud, managing 65+ petabytes of biomedical data for 12,000+ users across 48 countries; $200M Series I led by Blackstone Growth; serves 7 of top 10 pharma and 8 of top 10 diagnostics companies.
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a secure, scalable, and regulatory-compliant cloud environment where pharmaceutical companies, genomics labs, biobanks, health systems, and research institutions can store, analyze, and share multimodal biomedical data — including genomic sequences, clinical records, imaging, and real-world evidence. The platform is purpose-built for the data types, compliance requirements, and computational workloads unique to biomedical research and precision medicine development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.